PAHC - PHIBRO ANIMAL HEALTH CORP
IEX Last Trade
20.95
-0.025 -0.119%
Share volume: 4,415
Last Updated: Fri 27 Dec 2024 08:29:55 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$20.98
-0.03
-0.12%
Fundamental analysis
34%
Profitability
23%
Dept financing
40%
Liquidity
73%
Performance
33%
Performance
5 Days
0.18%
1 Month
-8.10%
3 Months
-1.77%
6 Months
26.05%
1 Year
86.25%
2 Year
62.89%
Key data
Stock price
$20.95
DAY RANGE
$20.92 - $21.62
52 WEEK RANGE
$10.79 - $25.98
52 WEEK CHANGE
$87.22
DIVIDEND
$0.12
EX-DIVIDEND DATE
06/05/2024
NEXT EARNINGS DATE
11/06/2024
Company detail
CEO: Jack C. Bendheim
Region: US
Website: pahc.com
Employees: 1,860
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: pahc.com
Employees: 1,860
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases.
Recent news